2024.Jun.19

Announcement on behalf of OBIGEN of resolution to lift the non-competition restrictions for new directors

1.Date of the shareholders’ meeting resolution:2024/06/19 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director Frank Chen, Representative of OBI Pharma Inc. Director Heidi Wang, Representative of OBI Pharma Inc. Director Jo Ma, Representative of OBI Pharma Inc. Director Hsing-Ming Chen, Representative of OBI Pharma Inc. Director Chung Yao […]

This article is password protected.

To view the content, please enter your password in the field below